NCT06980922View on ClinicalTrials.gov

The Efficacy and Safety of Guilu Erxian Jiao in the Treatment of Intradialytic Hypotension

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2028

Conditions
Intradialytic HypotensionEnd-Stage Renal DiseaseHemodialysis
Interventions
DRUG

Guilu Erxian Jiao

A traditional Chinese herbal formula composed of Testudinis Carapax, Cervi Cornu, Lycii Fructus, and Ginseng Radix, manufactured by Sun Ten Pharmaceutical Co., Ltd. (License No. 016966). Administered orally at 4 grams per day before meals for 4 weeks.

Trial Locations (1)

Unknown

Keelung Chang Gung Memorial Hospital, Keelung

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER